8-K
filed January 13, 2023, 6:59 PM ET
ticker VTAK
CIK 0001716621
M&A
confidence high
sentiment neutral
materiality 0.85
Catheter Precision, Inc. (VTAK): M&A transaction — Ra Medical acquires Catheter Precision; shifts focus to electrophysiology products
Catheter Precision, Inc.
- Acquired Catheter for ~14,650 Series X Preferred shares; Catheter debt converted at $3.20 per 1/1000th share.
- Warrants repriced to $4 from $14–$526; Armistice exercises ~332K warrants for $1.3M gross proceeds.
- Private placement of $8M with Armistice via Class A/B units, subject to stockholder approval.
- Board changes: Richard Mejia, Joan Stafslien resigned; David Jenkins appointed Executive Chairman, James Caruso appointed.
- Post-merger company will not use legacy assets; focus shifts to Catheter's VIVO, Amigo, and vessel closure device.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
James Caruso was appointed as Director at Catheter Precision, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
Pursuant to the terms of the Merger Agreement, as of immediately following the First Effective Time, Richard Mejia, Jr. and Joan Stafslien resigned from the Board of Directors and any committees of the Board of Directors to which they belonged and David Jenkins (Class II) and James Caruso (Class III) were appointed to the Board of Directors, with Mr. Jenkins becoming Executive Chairperson of the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Richard Mejia, Jr. resigned as Director at Catheter Precision, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Pursuant to the terms of the Merger Agreement, as of immediately following the First Effective Time, Richard Mejia, Jr. and Joan Stafslien resigned from the Board of Directors and any committees of the Board of Directors to which they belonged and David Jenkins (Class II) and James Caruso (Class III) were appointed to the Board of Directors, with Mr. Jenkins becoming Executive Chairperson of the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Joan Stafslien resigned as Director at Catheter Precision, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Pursuant to the terms of the Merger Agreement, as of immediately following the First Effective Time, Richard Mejia, Jr. and Joan Stafslien resigned from the Board of Directors and any committees of the Board of Directors to which they belonged and David Jenkins (Class II) and James Caruso (Class III) were appointed to the Board of Directors, with Mr. Jenkins becoming Executive Chairperson of the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
David Jenkins was appointed as Executive Chairperson of the Board at Catheter Precision, Inc..
- Action
- appointed
- Role
- Executive Chairperson of the Board
Exact text from the filing
Pursuant to the terms of the Merger Agreement, as of immediately following the First Effective Time, Richard Mejia, Jr. and Joan Stafslien resigned from the Board of Directors and any committees of the Board of Directors to which they belonged and David Jenkins (Class II) and James Caruso (Class III) were appointed to the Board of Directors, with Mr. Jenkins becoming Executive Chairperson of the Board
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Catheter Precision, Inc.: Filed Certificate of Designation for Series X Convertible Preferred Stock establishing rights, preferences, and limitations (effective 2023-01-09).
- Change
- charter amendment
- Effective
- 2023-01-09
Exact text from the filing
On January 9, 2023, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series X Convertible Preferred Stock with the Secretary of State of the State of Delaware (the “Series X Certificate of Designation”)
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Catheter Precision, Inc. completed an acquisition involving Catheter Precision, Inc. (closed 2023-01-09).
- Action
- acquisition
- Counterparty
- Catheter Precision, Inc.
- Closing
- 2023-01-09
Exact text from the filing
On January 9, 2023, Ra Medical Systems, Inc., a Delaware corporation (the “Company” or “Ra Medical”), completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation (“Catheter”), pursuant to an Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”)
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Catheter Precision, Inc. entered into Amended and Restated Agreement and Plan of Merger with Catheter Precision, Inc., Rapid Merger Sub 1, Inc., and Rapid Merger Sub 2, LLC (effective 2023-01-09).
- Action
- entry
- Agreement
- merger
- Counterparty
- Catheter Precision, Inc., Rapid Merger Sub 1, Inc., and Rapid Merger Sub 2, LLC
- Effective
- 2023-01-09
Exact text from the filing
On January 9, 2023, Ra Medical Systems, Inc., a Delaware corporation (the “Company” or “Ra Medical”), completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation (“Catheter”), pursuant to an Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, Catheter, Rapid Merger Sub 1, Inc., a newly-created wholly-owned subsidiary of the Company (“First Merger Sub”), and Rapid Merger Sub 2, LLC, a newly-created wholly owned subsidiary of the Company (“Second Merger Sub” and together with First Merger Sub, the “Merger Subs”), entered into on January 9, 2023
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.